Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF837 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNF85 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | ZNF850 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | ZNF878 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
mRNA | ZNF91 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
mRNA | ZNRF1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZSCAN16 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |